Renaissance Technologies
SNTI icon

Renaissance Technologies’s Senti Biosciences Holdings SNTI Stock Holding History

Renaissance Technologies’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-51,600
Closed -$181K – 3814
2024
Q4 		$181K Buy
+51,600
New +$165K ﹤0.01% 3193
2024
Q2 		– Sell
-2,410
Closed -$9K – 3928
2024
Q1 		$9K Buy
+2,410
New +$10.8K ﹤0.01% 3628
2023
Q3 		– Sell
-1,730
Closed -$11K – 4080
2023
Q2 		$11K Buy
+1,730
New +$16.9K ﹤0.01% 3826
2023
Q1 		– Sell
-1,770
Closed -$25K – 4360
2022
Q4 		$25K Buy
+1,770
New +$43.2K ﹤0.01% 3928

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
8GI
8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies's SNTI Position: Q1 2025 in Review

Renaissance Technologies sold out of Senti Biosciences Holdings (SNTI) in Q1 2025, closing a stake of 51,600 shares — an estimated $181K sold.

Renaissance Technologies first reported a position in SNTI in Q4 2022 and held it in 4 quarters. The position peaked at $181K in Q4 2024. 16 funds tracked by Wall St. Rank hold SNTI as of Q1 2025.

  • Renaissance Technologies reported no remaining Senti Biosciences Holdings position as of Q1 2025 after selling out during the quarter.
  • Renaissance Technologies sold 51,600 Senti Biosciences Holdings shares in Q1 2025, an estimated $181K.
  • Renaissance Technologies first reported a position in Senti Biosciences Holdings in Q4 2022 and held it in 4 quarters.
  • Renaissance Technologies's Senti Biosciences Holdings position peaked at $181K in Q4 2024.
  • 16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2025.

Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.